SPACInsider Logo
EdtechX Holdings Re-Files Prospectus with a Change
by Kristi Marvin on 2018-09-25 at 12:01pm

EdtechX Holdings Acquisition Corp., re-filed their $55 million SPAC IPO today, with one change to their Crescent Term.

Previously, EdtechX’s term, regarding adjustment to the per-share redemption trigger, stated they would adjust the price to be equal to 240% of the market value of their common stock based on the 20-day trading period prior to the day on which they consummate their business combination.  This has been adjusted to 165%.

If you recall, EdtechX’s redemption trigger for the warrants to be sold in the IPO is $16.50, so now the 165% adjustment for any new capital raises done at combination below $9.50, will reflect an equal value to the original trigger.

If you would like a more detailed explanation of how the Crescent Term works, you can read about it here in the original post regarding EdtechX’s initial filing.

The rest of EdtechX’s terms remain the same, but as a reminder, a summary has been provided below.

EdtechX Holdings Summary of Terms:
  • Focus:  Education/EdTech
  • Size: $55 million
  • 101.5% held in trust ($10.15 per share)
  • $10.00 unit comprised of one share of Common Stock + one full Warrant 
  • Warrant call for redemption threshold: equals or exceeds $16.50 (cash or cashless exercise)
  • 18 months to complete an acquisition + 3 months extension if:
    • A proxy for a proposed business combination has been filed AND;
    • The price of the common stock equals or exceeds the estimated per-share value of the amount in the trust on the 18-month anniversary of the consummation of the offering for any 20 trading days within the 30 trading day period ending 17 months post-IPO.
  • Limitation on Redemption Rights: 20%
  • At-risk Capital: $3.45 million (3,450,000 warrants at $1.00)
  • Forward Purchase Agreement: 
    • Azimut Investors will purchase up to 2,000,000 units at $10.00 per unit (or up to $20,000,000)
  • Underwriter fees: 2.5% + 3.5% deferred. 
  • Includes “Crescent Term”

 

Chardan and I-Bankers Securities are joint book-running managers.

Graubard Miller and Schiff Hardin LLP are Issuer’s Counsel and Underwriter’s Counsel, respectively.

 

 

Recent Posts
by Kristi Marvin on 2023-03-25 at 12:14pm

Terms Tracker for the Week Ending March 24, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. While this week was relatively quiet on the filings front, we did see March’s second SPAC IPO price with Oak Woods Acquisition Corp’s $50 million...

by Marlena Haddad on 2023-03-24 at 5:40pm

Latest Non-Redemption Agreements: ExcelFin Acquisition Corp. ExcelFin Acquisition Corp. (XFIN) Adds Non-Redemption Agreement In connection with the special meeting of stockholders of ExcelFin Acquisition Corp. (NASDAQ:XFIN) to extend its completion deadline from April 25, 2023 to October 25, 2023, the company and its sponsor, ExcelFin SPAC LLC, entered into a non-redemption agreement with an unaffiliated third party....

by Marlena Haddad on 2023-03-24 at 11:33am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News:  Momentus SPAC backers accused of deliberately engineering a catastrophic deal  Momentus SPAC Backers Accused of Hiding Disastrous Deal’s Flaws A Momentus Inc. (NASDAQ:MNTS) investor sued backers of its blank-check merger with a shell company,...

by Nicholas Alan Clayton on 2023-03-24 at 7:20am

DiamondHead Holdings Corp. (NASDAQ:DHHC) announced in an 8-K this morning that its shareholders approved its combination with Great Southern Homes at a special meeting March 23. Only 109,426 shares were redeemed in the connection with the vote, but DiamondHead has seen about 87% redemptions in total across all previous votes, leaving it with about $43.9...

by Nicholas Alan Clayton on 2023-03-24 at 7:05am

Graf Acquisition Corp. IV (NYSE:GFOR) announced that it has signed a non-binding letter of intent to combine with clinical-stage biopharma company NKGen. This announcement is not a pure teaser as Graf IV is not facing an imminent extension vote and currently has until May 25 on its clock. It does, however, signal something of a...

Privacy Policy|Terms Of Use
Copyright © 2023 SPACInsider, Inc. All Rights Reserved